Ibotta Inc
For the period ended Mar 31, 2024. Filed May 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 31, 2024
IBTA$59.91+3.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
(In thousands)
| Three months ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities | ||
| Net income (loss) | $9,297 | $(4,283) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 1,909 | 1,615 |
| Impairment of capitalized software development costs | 92 | 320 |
| Stock-based compensation expense | 1,814 | 1,829 |
| Common stock warrant expense | 3,031 | – |
| Credit loss expense | 81 | 308 |
| Amortization of debt discount and issuance costs | 826 | 816 |
| Change in fair value of convertible notes derivative liability | 1,700 | 1,500 |
| Other | (3) | (53) |
| Changes in assets and liabilities: | ||
| Accounts receivable | 19,925 | 3,679 |
| Other current and long-term assets | (2,136) | (1,094) |
| Accounts payable | (1,214) | (619) |
| Due to third-party publishers | (5,632) | 6,617 |
| Accrued expenses | (10,197) | (9,376) |
| Deferred revenue | 1,562 | 1,135 |
| User redemption liability | (1,541) | 499 |
| Other current and long-term liabilities | (148) | (201) |
| Net cash provided by operating activities | 19,366 | 2,692 |
| Investing activities | ||
| Additions to property and equipment | (152) | (11) |
| Additions to capitalized software development costs | (2,315) | (995) |
| Maturities of short-term investments | – | 10,500 |
| Net cash (used in) provided by investing activities | (2,467) | 9,494 |
| Financing activities | ||
| Proceeds from exercise of stock options | 1,799 | 260 |
| Deferred offering costs | (1,700) | – |
| Other financing activities | (90) | – |
| Net cash provided by financing activities | 9 | 260 |
| Net change in cash and cash equivalents | 16,908 | 12,446 |
| Cash and cash equivalents, beginning of period | 62,591 | 17,818 |
| Cash and cash equivalents, end of period | $79,499 | $30,264 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.